ACRX
ACRX Real Time Price USDRecent trades of ACRX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ACRX's directors and management
Government lobbying spending instances
-
$50,000 Jul 20, 2022 Issue: Defense Health Issues
-
$50,000 Apr 20, 2022 Issue: Defense Health Issues
-
$50,000 Jan 18, 2022 Issue: Health Issues Defense
-
$50,000 Oct 23, 2021 Issue: Defense Health Issues
-
$50,000 Jul 22, 2021 Issue: Health Issues Defense
-
$50,000 Apr 20, 2021 Issue: Defense Health Issues
-
$50,000 Jan 20, 2021 Issue: Health Issues Defense
-
$50,000 Oct 20, 2020 Issue: Health Issues Defense
-
$50,000 Jul 20, 2020 Issue: Health Issues Defense
-
$50,000 Apr 21, 2020 Issue: Defense Health Issues
-
$50,000 Jan 21, 2020 Issue: Health Issues
-
$50,000 Oct 18, 2019 Issue: Health Issues
-
$50,000 Jul 12, 2019 Issue: Health Issues
-
$45,000 Apr 04, 2019 Issue: Health Issues
-
$30,000 Jan 09, 2019 Issue: Health Issues
-
$50,000 Oct 10, 2018 Issue: Health Issues
-
$50,000 Jul 09, 2018 Issue: Health Issues
-
$50,000 Apr 06, 2018 Issue: Health Issues
-
$45,000 Jan 12, 2018 Issue: Defense Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ACRX in WallStreetBets Daily Discussion
Recent insights relating to ACRX
Recent picks made for ACRX stock on CNBC
ETFs with the largest estimated holdings in ACRX
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ACRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.